We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $9.37B
1-Year Est. Return 36.4%
This Fund
S&P 500
This Quarter Est. Return
+9.21%
1 Year Est. Return
+36.4%
3 Year Est. Return
+114.29%
5 Year Est. Return
+137.63%
10 Year Est. Return
+535.77%
AUM
$4.04B
AUM Growth
+$368M
Cap. Flow
+$68.3M
Cap. Flow %
1.69%
Top 10 Hldgs %
14.84%
Holding
1,360
New
108
Increased
584
Reduced
484
Closed
87

Top Buys

Rank Stock Value
1
DOCU
DocuSign
DOCU
+$4.67M
2
ADBE icon
Adobe
ADBE
+$4.33M
3
PWR icon
Quanta Services
PWR
+$3.93M
4
SPYD icon
State Street SPDR Portfolio S&P 500 High Dividend ETF
SPYD
+$3.61M
5
BMY icon
Bristol-Myers Squibb
BMY
+$3.61M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$6.53M
2
AAPL icon
Apple
AAPL
+$5.68M
3
IHI icon
iShares US Medical Devices ETF
IHI
+$4.6M
4
IYC icon
iShares US Consumer Discretionary ETF
IYC
+$4.11M
5
STZ icon
Constellation Brands
STZ
+$3.98M

Sector Composition

Rank Sector Weight
1 Technology 14.02%
2 Healthcare 12.17%
3 Financials 11.29%
4 Consumer Discretionary 8.82%
5 Industrials 8.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IBRX icon
1251
ImmunityBio
IBRX
$8.1B
$59K ﹤0.01%
15,600
-17,000
-52% -$28.9K
PIM
1252
Franklin Master Intermediate Income Trust
PIM
$151M
$59K ﹤0.01%
+12,352
New +$58K
CX icon
1253
Cemex
CX
$16.3B
$58K ﹤0.01%
15,240
– –
S
1254
DELISTED
Sprint Corporation
S
$53K ﹤0.01%
10,091
-160
-2% -$938
PDLI
1255
DELISTED
PDL BioPharma, Inc.
PDLI
$49K ﹤0.01%
15,188
– –
AMRS
1256
DELISTED
Amyris Inc.
AMRS
$43K ﹤0.01%
14,000
+4,000
+40% +$14.8K
ADMA icon
1257
ADMA Biologics
ADMA
$2.22B
$40K ﹤0.01%
+10,026
New +$43.7K
WATT icon
1258
Energous
WATT
$102M
$34K ﹤0.01%
32
-24
-43% -$35.7K
HIMX
1259
Himax Technologies
HIMX
$2.55B
$33K ﹤0.01%
12,240
– –
KOPN icon
1260
Kopin
KOPN
$791M
$32K ﹤0.01%
80,500
-22,000
-21% -$11.3K
WTER
1261
DELISTED
The Alkaline Water Company Inc. Common Stock
WTER
$31K ﹤0.01%
+1,627
New +$31.9K
MIND icon
1262
MIND Technology
MIND
$46.2M
$29K ﹤0.01%
1,000
– –
JCP
1263
DELISTED
J.C. Penney Company, Inc.
JCP
$29K ﹤0.01%
26,000
-1,300
-5% -$1.38K
NGD
1264
DELISTED
New Gold Inc
NGD
$25K ﹤0.01%
28,146
– –
VBIV
1265
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$22K ﹤0.01%
+530
New +$11.6K
ROYT
1266
DELISTED
PACIFIC COAST OIL TRUST
ROYT
$21K ﹤0.01%
40,295
– –
OPK icon
1267
Opko Health
OPK
$1.02B
$16K ﹤0.01%
10,700
+486
+5% +$814
ATHX
1268
DELISTED
Athersys, Inc. Common Stock
ATHX
$12K ﹤0.01%
400
– –
DMK
1269
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$11K ﹤0.01%
229
– –
AMPE
1270
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$6K ﹤0.01%
34
– –
GSAT icon
1271
Globalstar
GSAT
$10.8B
$5K ﹤0.01%
680
– –
ATNM icon
1272
Actinium Pharmaceuticals
ATNM
$25M
$3K ﹤0.01%
467
-7,709
-94% -$53.2K
ADNT icon
1273
Adient
ADNT
$1.5B
– –
-9,255
Closed -$212K
ATRA icon
1274
Atara Biotherapeutics
ATRA
$76.1M
– –
-507
Closed -$179K
BFH icon
1275
Bread Financial
BFH
$4.38B
– –
-4,140
Closed -$424K
49 50
51
52 53

Similar funds

AC
Allstate Corporation Northbrook, Illinois $9.35B AUM 16.13% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
PVI
Partners Value Investments Hamilton, Bermuda $9.34B AUM 12.2% 1-Year Est. Return
WPL
WINDACRE PARTNERSHIP LLC Houston, Texas $9.34B AUM 17.41% 1-Year Est. Return
IAA
Independent Advisor Alliance Charlotte, North Carolina $9.32B AUM 33.19% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
SIM
SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return

Oppenheimer & Co's Q4 2019 Portfolio in Review

As of Q4 2019, Oppenheimer & Co held 1,360 positions worth $4.04B, up 10% from $3.67B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Oppenheimer & Co's Q4 2019 filing shows 108 new, 584 increased, 484 reduced and 87 closed positions. Its largest new stake was CAE Inc. Common Shares: 78,310 shares worth $2.07M. The largest sale was Celgene Corp, an estimated $6.53M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.

  • Oppenheimer & Co's largest Q4 2019 buy was CAE Inc. Common Shares: 78,310 shares worth $2.07M.
  • Oppenheimer & Co added most to DocuSign in Q4 2019, an estimated $4.67M increase.
  • Oppenheimer & Co's biggest Q4 2019 reduction was Apple, cutting an estimated $5.68M.
  • Oppenheimer & Co fully exited Celgene Corp in Q4 2019, selling an estimated $6.53M.
  • Oppenheimer & Co's ten largest holdings make up 15% of its $4.04B portfolio in Q4 2019.
  • Oppenheimer & Co opened 108 new positions and closed 87 in Q4 2019.
  • Oppenheimer & Co's portfolio value rose 10% quarter-over-quarter to $4.04B.

Based on Oppenheimer & Co's 13F filing for Q4 2019, filed 7 Feb 2020.